MedTrace Logo

30Gy Versus 40Gy Involved-field Radiotherapy for Localized Diffuse Large B Cell Lymphoma Achieving CR After Chemotherapy

NCT01156259 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2010-07-02

No results posted yet for this study

Summary

The purpose of this study is to determine whether 30Gy Involved-field Radiotherapy (IFRT) is as effective as 40Gy in the treatment of localized Diffused Large B cell Lymphoma (DLBCL) when completing CR after chemotherapy.

Conditions

  • Lymphoma, Large B-Cell, Diffuse

Interventions

RADIATION

3D-CRT based Involved Field Radiotherapy

CT simulation, 3D-CRT or IMRT techniques, Involved Field Radiotherapy of 30Gy

RADIATION

3D-CRT based Involved Field Radiotherapy

CT simulation, 3D-CRT or IMRT techniques, Involved Field Radiotherapy of 40Gy

Sponsors & Collaborators

  • Sun Yat-sen University

    collaborator OTHER

  • Chinese Academy of Medical Sciences

    lead OTHER

Principal Investigators

  • Yexiong Li, MD · Department of Radiation Oncology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2015-04-30
Completion
2015-05-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01156259 on ClinicalTrials.gov